Susan Moran's Insider Trades & SAST Disclosures
Susan Moran's most recent trade in BioAtla Inc was a trade of 16,500 Common Stock done . Disclosure was reported to the exchange on June 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Susan Moran.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAtla Inc | Susan Moran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,500 | 28,807 | - | 0 | Common Stock | |
| Boston Scientific Corp. | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 1,450 | 3,532 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 1,450 | 3,532 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 421 | 3,953 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 421 | 3,953 | - | - | Deferred Stock Units | |
| Tyra Biosciences Inc | Susan Moran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 37,200 | 37,200 | - | - | Common Stock (Right to Buy) | |
| RayzeBio Inc. | Moran Susan | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 62.50 per share. | 26 Feb 2024 | 323,455 | 0 | - | 62.5 | 20,215,938 | Common Stock |
| RayzeBio Inc. | Moran Susan | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2024 | 194,514 | 0 | - | - | Employee Stock Option (right to buy) | |
| RayzeBio Inc. | Moran Susan | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2024 | 164,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| RayzeBio Inc. | Susan Moran | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2024 | 77,805 | 0 | - | - | Employee Stock Option (right to buy) | |
| RayzeBio Inc. | Susan Moran | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2024 | 60,757 | 0 | - | - | Employee Stock Option (right to buy) | |
| RayzeBio Inc. | Susan Moran | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2024 | 30,875 | 60,757 | - | - | Employee Stock Option (right to buy) | |
| RayzeBio Inc. | Susan Moran | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.24 per share. | 22 Jan 2024 | 30,875 | 322,647 | - | 3.2 | 100,035 | Common Stock |
| Boston Scientific Corp. | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 1,626 | 1,626 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 1,626 | 1,626 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 456 | 2,082 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 456 | 2,082 (0%) | 0% | 0 | Common Stock | |
| BioAtla Inc | Susan Moran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| BioAtla Inc | Susan Moran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 12,307 | 12,307 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges